Michael Hanna

3.1k total citations
44 papers, 2.2k citations indexed

About

Michael Hanna is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Internal Medicine. According to data from OpenAlex, Michael Hanna has authored 44 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cardiology and Cardiovascular Medicine, 8 papers in Epidemiology and 7 papers in Internal Medicine. Recurrent topics in Michael Hanna's work include Atrial Fibrillation Management and Outcomes (33 papers), Cardiac Arrhythmias and Treatments (16 papers) and Cardiac electrophysiology and arrhythmias (12 papers). Michael Hanna is often cited by papers focused on Atrial Fibrillation Management and Outcomes (33 papers), Cardiac Arrhythmias and Treatments (16 papers) and Cardiac electrophysiology and arrhythmias (12 papers). Michael Hanna collaborates with scholars based in United States, Sweden and Australia. Michael Hanna's co-authors include Renato D. Lópes, John H. Alexander, Lars Wallentin, Christopher B. Granger, Bernard J. Gersh, Elaine M. Hylek, John D. Horowitz, Ziad Hijazi, Sana M. Al‐Khatib and Ulrika Andersson and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Neurology.

In The Last Decade

Michael Hanna

42 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Hanna United States 20 2.0k 773 293 160 141 44 2.2k
Laila Stærk Denmark 23 2.2k 1.1× 565 0.7× 255 0.9× 168 1.1× 21 0.1× 44 2.5k
Christine S. Zuern Germany 22 1.4k 0.7× 171 0.2× 433 1.5× 97 0.6× 48 0.3× 75 1.7k
Jon Blatchford United States 12 1.2k 0.6× 366 0.5× 250 0.9× 53 0.3× 15 0.1× 21 1.5k
Ribo Tang China 22 1.6k 0.8× 114 0.1× 107 0.4× 96 0.6× 32 0.2× 150 1.8k
Moisés Rodríguez‐Mañero Spain 24 2.0k 1.0× 141 0.2× 100 0.3× 112 0.7× 29 0.2× 203 2.3k
Li‐Wei Lo Taiwan 37 3.8k 1.9× 359 0.5× 320 1.1× 259 1.6× 9 0.1× 140 3.9k
Murat Çaylı Türkiye 19 800 0.4× 145 0.2× 188 0.6× 283 1.8× 41 0.3× 134 1.4k
Frederic Kontny Norway 17 1.6k 0.8× 330 0.4× 65 0.2× 421 2.6× 49 0.3× 49 1.9k
Juan Quiles Spain 21 1.0k 0.5× 109 0.1× 172 0.6× 359 2.2× 38 0.3× 69 1.5k
Casper H. Jørgensen Denmark 12 627 0.3× 165 0.2× 91 0.3× 36 0.2× 190 1.3× 19 1.4k

Countries citing papers authored by Michael Hanna

Since Specialization
Citations

This map shows the geographic impact of Michael Hanna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hanna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hanna more than expected).

Fields of papers citing papers by Michael Hanna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hanna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hanna. The network helps show where Michael Hanna may publish in the future.

Co-authorship network of co-authors of Michael Hanna

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Hanna. A scholar is included among the top collaborators of Michael Hanna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Hanna. Michael Hanna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hanna, Michael, et al.. (2024). An Adapted ARP-Based Approach for the System Safety Assessment of Electric-Propulsion Thermal Runaway Hazards. SAE International Journal of Advances and Current Practices in Mobility. 6(6). 3120–3128.
2.
3.
4.
Washam, Jeffrey B., Stefan H. Hohnloser, Renato D. Lópes, et al.. (2019). Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial. Journal of Thrombosis and Thrombolysis. 47(3). 345–352. 11 indexed citations
5.
Fudim, Marat, Renato D. Lópes, John H. Alexander, et al.. (2018). THE EFFICACY AND SAFETY OF APIXABAN VERSUS WARFARIN ARE PRESERVED IN PATIENTS WITH ATRIAL FIBRILLATION AND EXTREMELY HIGH BODY WEIGHT: INSIGHTS FROM THE ARISTOTLE STUDY. Journal of the American College of Cardiology. 71(11). A295–A295. 1 indexed citations
6.
Washam, Jeffrey B., Stefan H. Hohnloser, Daniel Wojdyla, et al.. (2017). USE OF INTERACTING DRUGS DID NOT MODIFY TREATMENT EFFECTS OF APIXABAN VERSUS WARFARIN FOR ATRIAL FIBRILLATION: RESULTS FROM THE ARISTOTLE TRIAL. Journal of the American College of Cardiology. 69(11). 442–442. 1 indexed citations
7.
Sandhu, Roopinder K., Justin A. Ezekowitz, Ulrika Andersson, et al.. (2016). The ‘obesity paradox’ in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial. European Heart Journal. 37(38). 2869–2878. 187 indexed citations
8.
Avezum, Álvaro, Renato D. Lópes, Phillip J. Schulte, et al.. (2015). Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease. Circulation. 132(8). 624–632. 166 indexed citations
9.
Bahit, M. Cecilia, Renato D. Lópes, Daniel Wojdyla, et al.. (2015). Less non-major bleeding with apixaban versus warfarin among patients with atrial fibrillation : insights from the ARISTOTLE trial. European Heart Journal. 36. 338–339. 3 indexed citations
10.
Hijazi, Ziad, S. H. Hohnloser, Ulrika Andersson, et al.. (2015). Efficacy and safety of apixaban compared with warfarin in relation to renal function over time in patients with atrial fibrillation : Insights from the ARISTOTLE trial. European Heart Journal. 36. 339–339. 7 indexed citations
11.
Ezekowitz, Justin A., Basil S. Lewis, Renato D. Lópes, et al.. (2015). Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial. European Heart Journal - Cardiovascular Pharmacotherapy. 1(2). 86–94. 48 indexed citations
12.
13.
Flaker, Greg, Renato D. Lópes, Elaine M. Hylek, et al.. (2014). Amiodarone, Anticoagulation, and Clinical Events in Patients With Atrial Fibrillation. Journal of the American College of Cardiology. 64(15). 1541–1550. 81 indexed citations
14.
15.
Rao, Meena P., Sigrun Halvorsen, Daniel Wojdyla, et al.. (2014). POORLY CONTROLLED BLOOD PRESSURE IS INDEPENDENTLY ASSOCIATED WITH A 50% HIGHER RISK OF STROKE OR SYSTEMIC EMBOLISM IN PATIENTS WITH ATRIAL FIBRILLATION: RESULTS FROM THE ARISTOTLE TRIAL. Journal of the American College of Cardiology. 63(12). A362–A362. 1 indexed citations
16.
Al‐Khatib, Sana M., Laine Thomas, Lars Wallentin, et al.. (2013). Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial. European Heart Journal. 34(31). 2464–2471. 136 indexed citations
17.
Alexander, John H., Renato D. Lópes, John J.V. McMurray, et al.. (2012). EFFICACY AND SAFETY OF APIXABAN COMPARED WITH WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION IN PATIENTS TAKING CONCOMITANT ASPIRIN. Journal of the American College of Cardiology. 59(13). E1697–E1697. 5 indexed citations
18.
Loukas, Marios, et al.. (2010). Chiari’s network: review of the literature. Surgical and Radiologic Anatomy. 32(10). 895–901. 59 indexed citations
19.
Lechtenberg, Kelly, et al.. (2003). Efficacy of ceftiofur sodium for the control of mortality in neonatal pigs orally inoculated with K88+ (F4+) enterotoxigenic Escherichia coli. Journal of Swine Health and Production. 11(1). 7–11. 1 indexed citations
20.
Pavri, Behzad B., Dusan Z. Kocovic, & Michael Hanna. (1999). Long‐Short RR Intervals and the Right Bundle Branch. Journal of Cardiovascular Electrophysiology. 10(1). 121–123. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laila Stærk Breakdown of academic impact, for papers by Christine S. Zuern Breakdown of academic impact, for papers by Jon Blatchford Breakdown of academic impact, for papers by Ribo Tang Breakdown of academic impact, for papers by Moisés Rodríguez‐Mañero Breakdown of academic impact, for papers by Li‐Wei Lo Breakdown of academic impact, for papers by Murat Çaylı Breakdown of academic impact, for papers by Frederic Kontny Breakdown of academic impact, for papers by Juan Quiles Breakdown of academic impact, for papers by Casper H. Jørgensen
Rankless by CCL
2026